In recent years, it has been suggested that the overexpression of TFAP4 may indicate a poor prognosis for various cancers, including hepatocellular carcinoma (HCC), non‐small cell lung carcinoma (NSCLC), prostate cancer (PCa), colorectal cancer (CRC) and gastric cancer (GC).11, 12, 13, 14, 15. Here, TFAP4 is linked to cancer.